Kirvsy Pharmaceuticals Private Limited, a active private limited company, was established on 02 June 2017 in Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74999DL2017PTC318624. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹3.00 Cr.
It upholds a compliant status. Its leadership includes Rashmi Tyagi (Director), Mukesh Tyagi (Additional Director), Vikas Kumar (Director). It holds ₹4.95 Cr open charges and no settled loans. Its latest AGM occurred on 16 August 2024, with the balance sheet filed on 31 March 2024. It is based at Office No2B,L/G/F Plot No 16 Karkardooma Community Centre,Rishab Corporate Tower, Delhi, Delhi, 110092.
U74999DL2017PTC318624
318624
02 June 2017
₹3.00 Cr
₹3.00 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Kirvsy Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rashmi Tyagi | Director | 02 Jun 2017 | Current |
| Mukesh Tyagi | Additional Director | 19 Jan 2024 | Current |
| Vikas Kumar | Director | 02 Jun 2017 | Current |
| Shri Pal | Additional Director | 17 Jan 2025 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kirvsy Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 47.32% decrease. The company also saw a substantial fall in profitability, with a 615.75% decrease in profit. The company's net worth observed a substantial decline by a decrease of 34.14%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Kirvsy Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹49,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Oct 2022 | Others | ₹5.10 M | Open |
| 26 Aug 2020 | Others | ₹4.40 M | Open |
| 26 Apr 2019 | Others | ₹4.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Kirvsy Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Kirvsy Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kirvsy Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Shri Pal was appointed as a Additional Director was appointed as a Additional Director on 17 Jan 2025 & has been associated with this company since 10 months 16 days . was documented.
Progress on Kirvsy Pharmaceuticals Private Limited last Annual general meeting of members was held on 16 Aug 2024 as per latest MCA records. was documented.
Kirvsy Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
Progress on Mukesh Tyagi was appointed as a Additional Director was appointed as a Additional Director on 19 Jan 2024 & has been associated with this company since 1 year 10 months . was documented.
A charge with Others amounted to Rs. 0.51 Cr with Charge ID 100627872 was registered on 15 Oct 2022. was recorded as a recent event.
A charge with Others amounted to Rs. 0.44 Cr with Charge ID 100374729 was registered on 26 Aug 2020. was recorded as a recent event.
The CIN of Kirvsy Pharmaceuticals Private Limited is U74999DL2017PTC318624.
Kirvsy Pharmaceuticals Private Limited is headquartered at Office No2B,L/G/F Plot No 16 Karkardooma Community Centre,Rishab Corporate Tower, Delhi, Delhi, 110092.
Kirvsy Pharmaceuticals Private Limited was incorporated on 02 June 2017.
The current directors of Kirvsy Pharmaceuticals Private Limited are
The primary industry of Kirvsy Pharmaceuticals Private Limited is Manufacturing.
Kirvsy Pharmaceuticals Private Limited is unlisted.
The authorized capital of Kirvsy Pharmaceuticals Private Limited is ₹3.00 Cr, and the paid-up capital is ₹3.00 Cr.
The compliance status of Kirvsy Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX